As of 2024-09-09, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is 0.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is -64.62 mil USD. BLUE's TTM EBITDA according to its financial statements is -290.13 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 16.5x | 13.8x |
| Forward P/E multiples | 15.0x - 21.3x | 17.6x |
| Fair Price | (22.02) - (24.28) | (23.06) |
| Upside | -4264.1% - -4690.6% | -4460.0% |
| Date | EV/EBITDA |
| 2024-09-06 | 0.22 |
| 2024-09-05 | 0.20 |
| 2024-09-04 | 0.20 |
| 2024-09-03 | 0.20 |
| 2024-08-30 | 0.20 |
| 2024-08-29 | 0.18 |
| 2024-08-28 | 0.16 |
| 2024-08-27 | 0.16 |
| 2024-08-26 | 0.11 |
| 2024-08-23 | 0.12 |
| 2024-08-22 | 0.13 |
| 2024-08-21 | 0.10 |
| 2024-08-20 | 0.14 |
| 2024-08-19 | 0.12 |
| 2024-08-16 | 0.10 |
| 2024-08-15 | 0.11 |
| 2024-08-14 | 0.04 |
| 2024-08-13 | -0.13 |
| 2024-08-12 | -0.08 |
| 2024-08-09 | -0.08 |
| 2024-08-08 | -0.09 |
| 2024-08-07 | -0.05 |
| 2024-08-06 | -0.10 |
| 2024-08-05 | -0.08 |
| 2024-08-02 | -0.16 |
| 2024-08-01 | -0.14 |
| 2024-07-31 | -0.19 |
| 2024-07-30 | -0.17 |
| 2024-07-29 | -0.23 |
| 2024-07-26 | -0.23 |
| 2024-07-25 | -0.22 |
| 2024-07-24 | -0.18 |
| 2024-07-23 | -0.24 |
| 2024-07-22 | -0.18 |
| 2024-07-19 | -0.12 |
| 2024-07-18 | -0.18 |
| 2024-07-17 | -0.23 |
| 2024-07-16 | -0.32 |
| 2024-07-15 | -0.30 |
| 2024-07-12 | -0.23 |
| 2024-07-11 | -0.17 |
| 2024-07-10 | -0.11 |
| 2024-07-09 | -0.09 |
| 2024-07-08 | -0.04 |
| 2024-07-05 | -0.04 |
| 2024-07-03 | -0.03 |
| 2024-07-02 | -0.04 |
| 2024-07-01 | -0.07 |
| 2024-06-28 | -0.08 |
| 2024-06-27 | -0.05 |